These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4647857)

  • 1. Quantitative electromyography: carrier detection in Duchenne type muscular dystrophy using a new automatic technique.
    Moosa A; Brown BH; Dubowitz V
    J Neurol Neurosurg Psychiatry; 1972 Dec; 35(6):841-4. PubMed ID: 4647857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative EMG as a method of carrier detection in X-linked muscular dystrophy.
    Gardner-Medwin D
    Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):401. PubMed ID: 4176582
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of the carrier state in the Duchenne type of muscular dystrophy. 2. Quantitative electromyography as a method of carrier detection.
    Gardner-Medwin D
    J Neurol Neurosurg Psychiatry; 1968 Apr; 31(2):124-34. PubMed ID: 5684019
    [No Abstract]   [Full Text] [Related]  

  • 4. Carrier detection in the Duchenne type muscular dystrophy: preliminary observations on the place of electromyography.
    Jacobs K
    J Neurol Sci; 1968; 6(2):347-56. PubMed ID: 5707432
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative electromyography in the detection of the carriers in Duchenne type muscular dystrophy.
    Valli G; Scarlato G; Contartese M
    J Neurol; 1976 Apr; 212(2):139-49. PubMed ID: 57226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of electromyographic recordings in the detection of Duchenne's dystrophy carriers].
    Hausmanowa-Petrusewicz I; Matz B
    Neurol Neurochir Pol; 1977; 11(3):307-13. PubMed ID: 882206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative EMG and histological carrier detection of Duchenne muscular dystrophy.
    Scarlato G; Valli G; Meola G; Carenini L
    J Neurol; 1977 Nov; 216(4):235-49. PubMed ID: 72807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection of carriers of X-linked muscular dystrophy genes. A review of some methods studied in Newcastle upon Tyne.
    Gardner-Medwin D; Pennington RJ; Walton JN
    J Neurol Sci; 1971 Aug; 13(4):459-74. PubMed ID: 5570764
    [No Abstract]   [Full Text] [Related]  

  • 9. Disorder of muscle contraction processes in sex-linked (Duchenne) muscular dystrophy, with correlative electromyographic study of myopathic involvement in small hand muscles.
    Desmedt JE; Emeryk B
    Am J Med; 1968 Dec; 45(6):853-72. PubMed ID: 4235455
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
    Hughes RC; Park DC; Parsons ME; O'Brien MD
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duchenne muscular dystrophy manifesting carriers.
    Barkhaus PE; Gilchrist JM
    Arch Neurol; 1989 Jun; 46(6):673-5. PubMed ID: 2730379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nearest neighbour decision rule for EMG detection of carriers of Duchenne muscular dystrophy.
    Hausmanowa-Petrusewicz I; Wierzbicka M; Jozwik A; Szmidt-Salkowska E; Borkowska J
    Electromyogr Clin Neurophysiol; 1982; 22(6):445-57. PubMed ID: 7140630
    [No Abstract]   [Full Text] [Related]  

  • 13. [Present-day clinico-genetic framework of Duchenne's muscular dystrophy].
    Meola G
    Riv Neurol; 1989; 59(1):8-14. PubMed ID: 2669113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regeneration in Duchenne muscular dystrophy. Electromyographic evidence.
    Desmedt JE; Borenstein S
    Arch Neurol; 1976 Sep; 33(9):642-50. PubMed ID: 962646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection of female carriers of pseudohypertrophic muscular dystrophy.
    Kakulas BA; Knight JO; Gubbay SS; Mastaglia FL
    Proc Aust Assoc Neurol; 1968; 5(3):545-51. PubMed ID: 5709982
    [No Abstract]   [Full Text] [Related]  

  • 16. Human growth hormone and estrogens in boys with Duchenne muscular dystrophy.
    Chyatte SB; Rudman D; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS
    Arch Phys Med Rehabil; 1973 Jun; 54(6):248-53. PubMed ID: 4708006
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical symptoms in a female carrier of Duchenne muscular dystrophy.
    Zatz M; Levisky RB; Levy JA; Valente BO; Gianotti M; Frota-Pessoa O
    J Genet Hum; 1973 Dec; 21(4):297-305. PubMed ID: 4792239
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trial in Duchenne dystrophy. I. The design of the protocol.
    Brooke MH; Griggs RC; Mendell JR; Fenichel GM; Shumate JB; Pellegrino RJ
    Muscle Nerve; 1981; 4(3):186-97. PubMed ID: 7017401
    [No Abstract]   [Full Text] [Related]  

  • 19. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier detection in X-linked muscular dystrophy.
    Walton JN
    J Genet Hum; 1969 Oct; 17(3):497-510. PubMed ID: 5387424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.